lomustine has been researched along with Granuloma, Hodgkin in 155 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 34-year-old woman who had had intractable pruritus for 2 years experienced dramatic relief from the symptom under treatment with cimetidine." | 7.66 | [Pruritus in Hodgkin's disease responding to cimetidine]. ( Graf, W; Stäubli, M; Straub, PW, 1981) |
| "Neutrophilic eccrine hidradenitis has been described in patients with acute myelogenous leukemia and other malignant diseases, usually during chemotherapy." | 6.39 | Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis. ( Knowles, SR; Poldre, P; Shapiro, L; Shear, NH, 1996) |
| "In addition to mechlorethamine, lomustine and teniposide combinations were also linked to an elevated risk of developing leukemia." | 3.69 | Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. ( Chorus, AM; Hagenbeek, A; Noyon, R; Pinedo, HM; Somers, R; van den Belt-Dusebout, AW; van Kerkhoff, EH; van Leeuwen, FE, 1994) |
| "A 34-year-old woman who had had intractable pruritus for 2 years experienced dramatic relief from the symptom under treatment with cimetidine." | 3.66 | [Pruritus in Hodgkin's disease responding to cimetidine]. ( Graf, W; Stäubli, M; Straub, PW, 1981) |
| "The causes of death were Hodgkin's lymphoma in 36 patients, second neoplasms in 12, cardiorespiratory diseases in 4, pulmonary diseases in 2, and unknown in 6." | 2.72 | MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. ( Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F, 2006) |
| "A decreased incidence of interstitial pneumonitis as well as a possible benefit in efficacy has been reported with lomustine (CCNU) compared to BCNU in the standard dose setting." | 2.70 | Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. ( Blume, KG; Chao, NS; Horning, SJ; Johnston, LJ; Long, GD; Negrin, RS; Shizuru, JA; Stockerl-Goldstein, KE; Stuart, MJ; Wong, RM, 2001) |
| "Thirty-three evaluable patients with Hodgkin's disease who failed radiotherapy were treated on this phase II study with bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone given every 28 days for a minimum of eight courses." | 2.70 | Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481). ( Bennett, JM; Glick, JH; Habermann, TM; Leong, T; Neiman, RS; Oken, MM; Schuster, S; Wiernik, PH, 2001) |
| "With the success of treatment for Hodgkin disease in children, future research needs to be focused in reducing toxicity without altering the excellent actual outcome." | 2.68 | Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. ( Alderete, D; Alfaro, E; Casak, S; Chantada, G; Felice, MS; Gallo, G; Quinteros, R; Sackmann-Muriel, F; Scopinaro, M; Zubizarreta, P, 1997) |
| "Eighty patients with advanced Hodgkin's disease were randomized either to treatment with combination of doxorubicin, bleomycin, vinblastine, and prednisone (ABVP), alternating with lomustine, vincristine, procarbazine, and prednisone (LOPP)--Group A, or to combination of cyclophosphamide, vincristine, procarbazine, prednisone, and low dose of bleomycin (COPP-Bleo)--Group B." | 2.67 | Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease. ( Bohunický, L; Fuchsberger, P; Gyárfás, J; Koza, I; Mardiak, J; Mociková, K; Spánik, S; Sufliarsky, J; Svancárová, L; Thalmeinerová, Z, 1991) |
| "Although initial treatment of Hodgkin's disease induces a complete remission in most patients, approximately 50% of patients with advanced disease will not achieve a complete remission or will relapse following the first complete remission." | 2.67 | CEP regimen (CCNU, etoposide, prednimustine) for relapsed/refractory Hodgkin's disease. ( Ammendolia, I; Babini, L; Barbieri, E; Bendandi, M; Fiacchini, M; Gherlinzoni, F; Neri, S; Perini, F; Salvucci, M; Zinzani, PL, 1994) |
| "A substantial number of patients with Hodgkin's disease (HD) do not respond adequately to standard therapy." | 2.67 | Phase-II trial with M-CAVe-CEC as a salvage chemotherapeutic regimen for early relapsed or primary refractory Hodgkin's disease. ( de Pauw, BE; Jongen-Lavrencic, M; Raemaekers, JM; Vreugdenhil, G, 1994) |
| "65 adult patients with Hodgkin's disease were treated acc." | 2.67 | [Early results of the treatment of Hodgkin's disease in adults using the seven-drug cytostatic protocol]. ( Filip, A; Gabryś, K; Kotlarek-Haus, S; Kuliszkiewicz-Janus, M; Wołowiec, D, 1992) |
| "2676 Patients entered into Hodgkin's disease studies between February 1970 and November 1986." | 2.67 | Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation. ( Devereux, S; Linch, DC; Selassie, TG; Vaughan Hudson, B; Vaughan Hudson, G, 1990) |
| "With such an attitude towards Hodgkin's disease in children it is advisable to abandon exploration laparotomy with splenectomy depriving the patient of the massive depot of humoral (B cell) immunity and creating the danger of an aggressive course of intercurrent infections in splenectomized children affected with Hodgkin's disease." | 2.66 | [Evaluation of 5-year results of the scheduled treatment of lymphogranulomatosis in children]. ( Goldobenko, GV; Makhomova, LA; Poliakov, VE; Susuleva, NA; Tsygankin, VI, 1989) |
| "A total of 277 patients with untreated Hodgkin's disease, clinical stages I-II, were randomized to cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) alone for 6 monthly cycles or to CVPP plus radiation therapy (RT), 3,000 rad, to involved areas (CVPP plus RT)." | 2.66 | Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease. ( Corrado, C; Garcia, I; Magnasco, O; Maschio, M; Montero, C; Muriel, FS; Pavlovsky, S; Sanahuja, FL; Santarelli, MT; Schwartz, L, 1988) |
| "In patients with stage IV Hodgkin's disease mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) was randomly tested against MOPP alternated monthly with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD)." | 2.66 | Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. ( Bonadonna, G; Santoro, A; Valagussa, P, 1986) |
| " The dosage of CCNU was 100 mg/m2 p." | 2.65 | The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study. ( Brunner, K; Cuttner, J; Falkson, G; Hansen, HH; Holland, JF; Nissen, NI; Pajak, TF; Selawry, OS; Spurr, CL, 1981) |
| "We conclude that (1) survival of Hodgkin's disease of childhood has shown a rather marked improvement during the last decade and this progress is probably due to the use of combined multidrug chemotherapy administered under collaborative controlled clinical trials; (2) preliminary evaluation of the results of CVPP and CCVPP therapy shows that the latter combination (CCVPP) neither increases the percent of patients achieving complete remission nor prolongs relapse-survival in Hodgkin's disease of childhood: and (3) all stages of childhood Hodgkin's disease can be successfully managed with multidrug chemotherapy alone." | 2.65 | Hodgkin's disease in childhood: therapy results in Argentina. ( Bonesana, AC; Kvicala, R; Morgenfeld, M; Ojeda, F; Papendieck, C; Pavlovsky, S; Penchansky, L; Sackmann-Muriel, F; Schwartz, L; Sica, M, 1981) |
| "Eighteen patients with advanced Hodgkin's disease, refractory to combination chemotherapy with nitrogen mustard, vincristine, prednisone, and procarbazine (MOPP), were treated with vinblastine, doxorubicin (Adriamycin), bleomycin, CCNU, and dacarbazine (DTIC) (VABCD)." | 2.65 | Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine. ( Bond, WH; Chenoweth, L; Einhorn, LH; Stevens, EE; Williams, SD, 1983) |
| "Forty-seven patients with advanced Hodgkin's disease were entered in a prospective, randomized trial comparing MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) with a regimen containing lomustine (CCNU), vinblastine, and prednisone (CCNU-VP)." | 2.65 | Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. ( Bateman, JR; Hum, GJ; Liebman, HA; Ryden, VM; Sheehan, WW, 1983) |
| "The patients with advanced-stage Hodgkin's disease who did not achieve a complete remission from their initial treatment with combination chemotherapy have a dismal prognosis." | 2.40 | [The management of Hodgkin's disease with chemotherapy or combined modality treatment]. ( Shimoyama, M; Tsushita, K; Utsumi, M, 1998) |
| "Neutrophilic eccrine hidradenitis has been described in patients with acute myelogenous leukemia and other malignant diseases, usually during chemotherapy." | 2.39 | Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis. ( Knowles, SR; Poldre, P; Shapiro, L; Shear, NH, 1996) |
| "The cases of 63 children treated for Hodgkin's disease were retrospectively evaluated according to clinical and laboratory characteristics at initial appearance, clinical and pathologic staging, and treatment for their effects on survival and disease-free survival." | 2.38 | Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota. ( Aeppli, D; Day, DL; Heise, R; Lee, CK; McClain, KL; Woods, WG, 1990) |
| "This article reports a patient with Hodgkin's disease in remission after combined modality therapy who developed metastatic pulmonary osteosarcoma, subsequently found to originate in soft tissue of the mediastinum, within a field irradiated 11 years previously." | 2.37 | Mediastinal osteosarcoma with extension to lungs in a patient treated for Hodgkin's disease. ( Andres, DF; Catanese, J; Dorfman, HD; Dutcher, JP; Wiernik, PH, 1988) |
| "Ninety-two patients with Hodgkin lymphoma and 47 with non-Hodgkin lymphoma were enrolled." | 1.43 | LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy. ( Gore, A; Gupta, A; Jain, R; Jeevangi, N; Kannan, S; Khattry, N; Nair, R; Saikia, T; Thippeswamy, R, 2016) |
| "Spinal cord compression was diagnosed in 33 patients with Hodgkin's disease." | 1.35 | [Clinical features and combined treatment of the central nervous system in Hodgkin's disease]. ( Filatova, LV; Gershanovich, ML, 2008) |
| "Risk of leukemia was 0." | 1.30 | The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con ( Anselmo, AP; Baroni, CD; Bernasconi, C; Brusamolino, E; Klersy, C; Lazzarino, M; Lunghi, F; Mandelli, F; Maurizi-Enrici, R; Orlandi, E; Pagnucco, G; Santoro, M, 1998) |
| "Hodgkin's disease is curable in the majority of patients, although a proportion of patients are resistant to or relapse after initial therapy." | 1.30 | High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. ( Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D, 1999) |
| "Intracranial Hodgkin's disease is very rare and is often a terminal event." | 1.30 | Intracranial Hodgkin's disease in two patients with familial Hodgkin's disease. ( Agarwal, V; Ashigbi, MY; Bello, J; Venkatraj, U; Wiernik, PH, 1997) |
| " Data were analysed using noncompartmental pharmacokinetic methods." | 1.29 | Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patients. ( Blaschke, TF; Chao, NJ; Kastrissios, H, 1996) |
| "Management of Hodgkin's disease (HD) and large mediastinal adenopathy (LMA) usually includes intensive chemotherapy (CT) with or without radiation therapy (XT) regardless of stage." | 1.29 | Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches. ( Allen, PK; Besa, P; Cabanillas, F; Cox, JD; Hagemeister, FB; McLaughlin, P; Preti, A; Rodriguez, A; Swan, F, 1994) |
| "Patients whose Hodgkin's disease is refractory to standard combination chemotherapy usually have a poor prognosis." | 1.29 | Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease. ( al-Katib, A; Andersen, J; Bishop, CR; Hussein, ME; Karanes, C; Khanuja, PS; Smith, MR, 1994) |
| "28 patients suffering from advanced Hodgkin's disease were treated according to protocol containing 7 cytostatic drugs including methotrexate and corticosteroids, but not cyclophosphamide, chlormethine or procarbazine." | 1.29 | [Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate]. ( Gabryś, K; Kotlarek-Haus, S; Potoczek, S, 1995) |
| "Patients with advanced Hodgkin's disease failing to achieve complete remission with chemotherapy or developing disease progression within 1 year have a poor prognosis with salvage chemotherapy." | 1.29 | CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy. ( Fairey, AF; Jones, HW; Mead, GM; Sweetenham, JW; Whitehouse, JM, 1993) |
| "Forty-nine patients with Hodgkin's disease who relapsed after a first complete remission of more than 12 months following primary chemotherapy were treated with salvage therapy regimens." | 1.28 | Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. ( Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S, 1990) |
| "Many patients with advanced Hodgkin's disease continue to need palliative therapy, but where there is no curative intent, patients and doctors may prefer oral treatment only." | 1.28 | An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNU. ( Carey, PJ; Jackson, GH; Lennard, AL; Proctor, SJ, 1990) |
| " The CVPP schedule gave: (1) a constant drug dosage for each patient independent of body surface or weight; and (2) a total drug dosage dependent on haematological tolerance, since the treatment was given for 21 days or until the leukocyte count dropped to 2 x 10(9) l-1." | 1.28 | Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease. ( Bonichon, F; Chauvergne, J; de Mascarel, I; Eghbali, H; Hoerni, B; Lagarde, P, 1989) |
| "Although most patients with Hodgkin's disease refractory to MOPP treatment will respond to either ABVD or B-CAVe chemotherapy, subsequent long-term disease-free survival is unusual." | 1.27 | Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. ( Harker, WG; Kushlan, P; Rosenberg, SA, 1984) |
| "Secondary tumors were noted in 8 out of 675 patients with Hodgkin's disease during remission following treatment." | 1.27 | [Secondary malignant tumors following treatment of Hodgkin's disease]. ( Shishkin, IP, 1984) |
| "Appropriate management of Hodgkin's disease is based on both the stage of disease and the specific anatomic sites of involvement within each stage." | 1.27 | Diagnosis and management of Hodgkin's disease in the adult. ( Fuller, LM; Hagemeister, FB, 1983) |
| "In 164 patients with Hodgkin's disease staged between 1973 and 1979 the response to the 3 initial cycles of multiagent chemotherapy was evaluated as a prognosticator of survival." | 1.27 | Early response to chemotherapy as a prognostic factor in Hodgkin's disease. ( Bierling, P; Brun, B; Dreyfus, B; Farcet, JP; Imbert, M; Kuentz, M; Le Bezu, M; Lebourgeois, JP; Reyes, F; Rochant, H; Vernant, JP, 1983) |
| "Thirty-two patients with advanced Hodgkin's lymphoma resistant to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) were treated with a salvage chemotherapy regimen consisting of lomustine, etoposide, vindesine, and dexamethasone (CEVD)." | 1.27 | Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge ( Diehl, V; Fuchs, R; Loeffler, M; Pflüger, KH; Pfreundschuh, MG; Schoppe, WD, 1987) |
| "Fifty patients with recurrent Hodgkin's disease have been treated with high-dose therapy followed by autologous bone marrow transplantation." | 1.27 | High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report. ( Carella, AM; Cimino, G; Congiu, AM; Coser, P; Gaozza, E; Mangoni, L; Mazza, P; Meloni, G; Ricci, P; Visani, G, 1988) |
| "In 10 patients with heavily pretreated Hodgkin's disease (stage IVA or IVB) a third-line salvage therapy consisting of CCNU, etoposide and chlorambucil (CECh) was tested." | 1.27 | [Oral polychemotherapy in far advanced recurrences of Hodgkin's disease]. ( Mödder, B; Ollenschläger, G; Schaefer, HJ, 1988) |
| "Thirty-two patients with recurrent Hodgkin's disease have been treated with an oral regimen employing lomustine (CCNU, 100 mg/m2 orally on Day 1); etoposide (VP-16, 100 mg/m2 orally on Days 1-3 and 21-23); and methotrexate (30 mg/m2 orally on Days 1, 8, 21, and 28)." | 1.27 | Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate. ( Coleman, CN; Horning, SJ; Jacobs, C; Lewis, BJ; Rosenberg, SA; Tseng, A, 1987) |
| "Fifteen patients with Hodgkin's disease resistant to the chemotherapy combinations of cyclophosphamide, vinblastine, procarbazine and prednisone and doxorubicin, bleomycin, vinblastine, and dacarbazine were treated with lomustine, etoposide, and prednimustine." | 1.27 | Treatment of advanced resistant Hodgkin's disease with lomustine, etoposide, and prednimustine. ( Cervantes, F; Montserrat, E; Reverter, JC; Rozman, C, 1986) |
| "One patient with Hodgkin's disease involving the liver is alive at 36 months with further therapy." | 1.26 | Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease. ( Gamble, JF; Loh, KK; Rodgers, RW; Shullenberger, CC, 1980) |
| "In 18 patients with advanced Hodgkin's disease, refractory to previous 'C-MOPP' treatment, a new therapeutic protocol of adriamycin, DTIC, CCNU and bleomycin was introduced." | 1.26 | [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)]. ( Bruntsch, U; Gallmeier, WM; Osieka, R; Schmidt, CG; Seeber, S, 1976) |
| "Ten patients with advanced Hodgkin's disease refractory to combination therapy with nitrogen mustard, vincristine sulfate, procarbazine, and prednisone (MOPP) were treated with a combination of doxorubicin hydrochloride and lomustine." | 1.26 | Combination chemotherapy with doxorubicin and lomustine. Treatment of refractory Hodgkin's disease. ( Einhorn, LH; Williams, SD, 1977) |
| "Between 1967 and 1977, 48 patients with Hodgkin's disease under 16-years-old were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available." | 1.26 | Childhood Hodgkin's disease in Uganda: a ten year experience. ( Katongole-Mbidde, E; Kiire, C; Lwanga, SK; Magrath, I; Olweny, CL; Ziegler, JL, 1978) |
| "Fifty patients with advanced Hodgkin's disease were treated with a combination of cyclophosphamide, vinblastine, procarbazine and prednisone (CVPP) in a 21-day cyclic regimen." | 1.26 | Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease. ( Diggs, CH; Kvols, LK; Levi, JA; Wiernik, PH, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 88 (56.77) | 18.7374 |
| 1990's | 45 (29.03) | 18.2507 |
| 2000's | 14 (9.03) | 29.6817 |
| 2010's | 7 (4.52) | 24.3611 |
| 2020's | 1 (0.65) | 2.80 |
| Authors | Studies |
|---|---|
| Russler-Germain, DA | 1 |
| Watkins, MP | 1 |
| Bartlett, NL | 1 |
| Merli, F | 4 |
| Luminari, S | 4 |
| Gobbi, PG | 5 |
| Cascavilla, N | 1 |
| Mammi, C | 2 |
| Ilariucci, F | 1 |
| Stelitano, C | 4 |
| Musso, M | 1 |
| Baldini, L | 3 |
| Galimberti, S | 1 |
| Angrilli, F | 2 |
| Polimeno, G | 1 |
| Scalzulli, PR | 1 |
| Ferrari, A | 1 |
| Marcheselli, L | 3 |
| Federico, M | 7 |
| Khattry, N | 1 |
| Gupta, A | 1 |
| Jain, R | 1 |
| Gore, A | 1 |
| Thippeswamy, R | 1 |
| Jeevangi, N | 1 |
| Kannan, S | 1 |
| Nair, R | 1 |
| Saikia, T | 1 |
| Evens, AM | 1 |
| Hutchings, M | 1 |
| Diehl, V | 5 |
| Filatova, LV | 1 |
| Gershanovich, ML | 3 |
| Proctor, SJ | 2 |
| Lennard, AL | 2 |
| Jackson, GH | 2 |
| Jones, GL | 1 |
| Lewis, J | 1 |
| Wilkinson, J | 1 |
| White, J | 1 |
| Sieniawski, M | 1 |
| McKay, P | 1 |
| Culligan, D | 1 |
| Lucraft, HH | 1 |
| Morabito, F | 1 |
| Hohaus, S | 1 |
| Gentile, M | 1 |
| Montanini, A | 2 |
| La Sala, A | 2 |
| Scalone, R | 1 |
| Voso, MT | 1 |
| Iannitto, E | 4 |
| Gobbi, P | 2 |
| Chisesi, T | 3 |
| Bellei, M | 2 |
| Levis, A | 3 |
| Vitolo, U | 2 |
| Pavone, V | 3 |
| Liberati, M | 2 |
| Bordonaro, R | 2 |
| Pesce, EA | 1 |
| Ramzi, M | 1 |
| Mohamadian, M | 1 |
| Vojdani, R | 1 |
| Dehghani, M | 1 |
| Nourani, H | 1 |
| Zakerinia, M | 1 |
| Haghighinejad, H | 1 |
| Hallack Neto, AE | 1 |
| Borges dos Santos, K | 1 |
| Atalla, A | 1 |
| Chronowski, GM | 1 |
| Wilder, RB | 1 |
| Tucker, SL | 1 |
| Ha, CS | 1 |
| Sarris, AH | 1 |
| Hagemeister, FB | 4 |
| Barista, I | 1 |
| Hess, MA | 1 |
| Cabanillas, F | 3 |
| Cox, JD | 2 |
| Adiga, GU | 1 |
| Abebe, L | 1 |
| Wiernik, PH | 9 |
| Brice, P | 1 |
| Brugiatelli, M | 1 |
| Nagler, A | 1 |
| Gisselbrecht, C | 2 |
| Moretti, L | 1 |
| Colombat, P | 1 |
| Fabbiano, F | 1 |
| Di Renzo, N | 3 |
| Goldstone, A | 1 |
| Carella, AM | 2 |
| Broglia, C | 3 |
| Cavanna, L | 4 |
| Santini, G | 1 |
| Deliliers, GL | 1 |
| Angelucci, E | 1 |
| Valentino, F | 1 |
| Sacchi, S | 1 |
| Corbella, F | 1 |
| Molica, S | 2 |
| Corazza, GR | 1 |
| Orem, J | 1 |
| Fu, P | 1 |
| Ness, A | 1 |
| Mwanda, WO | 1 |
| Remick, SC | 1 |
| Perz, JB | 1 |
| Giles, C | 2 |
| Szydlo, R | 1 |
| O'Shea, D | 1 |
| Sanz, J | 1 |
| Chaidos, A | 2 |
| Wagner, S | 1 |
| Davis, J | 1 |
| Loaiza, S | 1 |
| Marin, D | 1 |
| Apperley, J | 2 |
| Olavarria, E | 1 |
| Rahemtulla, A | 1 |
| Lampert, I | 1 |
| Naresh, K | 1 |
| Samson, D | 1 |
| MacDonald, D | 1 |
| Kanfer, EJ | 1 |
| Gabriel, I | 1 |
| Bower, M | 1 |
| Gazzard, B | 1 |
| Kew, A | 1 |
| Nelson, M | 1 |
| Kanfer, E | 1 |
| Rodgers, RW | 1 |
| Gamble, JF | 1 |
| Loh, KK | 1 |
| Shullenberger, CC | 1 |
| Diggs, CH | 3 |
| Sutherland, JC | 1 |
| Sutcliffe, SB | 2 |
| Economopoulos, T | 1 |
| Wrigley, PF | 1 |
| Stansfeld, AG | 1 |
| Malpas, JS | 1 |
| García López, J | 1 |
| Diumenjo, MC | 1 |
| Argüelles, MV | 1 |
| Marín, P | 1 |
| Grañena, A | 1 |
| Montserrat, E | 3 |
| Rozman, C | 3 |
| Bloomfield, CD | 1 |
| Pajak, TF | 5 |
| Glicksman, AS | 2 |
| Gottlieb, AJ | 3 |
| Coleman, M | 3 |
| Nissen, NI | 5 |
| Rafla, S | 2 |
| Stutzman, L | 3 |
| Vinciguerra, V | 2 |
| Glidewell, OJ | 2 |
| Holland, JF | 7 |
| Mead, GM | 2 |
| Harker, WG | 2 |
| Kushlan, P | 2 |
| Rosenberg, SA | 4 |
| Bonadonna, G | 5 |
| Einhorn, LH | 2 |
| Williams, SD | 2 |
| Stevens, EE | 1 |
| Bond, WH | 1 |
| Chenoweth, L | 1 |
| Weiss, J | 1 |
| von Roemeling, R | 1 |
| Peters, HD | 1 |
| Schmoll, HJ | 1 |
| Straus, DJ | 5 |
| Myers, J | 4 |
| Koziner, B | 3 |
| Lee, BJ | 3 |
| Clarkson, BD | 3 |
| Nisce, LZ | 2 |
| McCormick, B | 1 |
| Kempin, S | 1 |
| Mertelsmann, R | 1 |
| Arlin, Z | 1 |
| Gee, T | 1 |
| Tannir, N | 1 |
| Hagemeister, F | 1 |
| Velasquez, W | 1 |
| Liebman, HA | 1 |
| Hum, GJ | 1 |
| Sheehan, WW | 1 |
| Ryden, VM | 1 |
| Bateman, JR | 1 |
| Cooper, MR | 2 |
| Nissen, N | 2 |
| Richards, F | 1 |
| Bloomfield, C | 1 |
| Ferme, C | 1 |
| Teillet, F | 1 |
| d'Agay, MF | 1 |
| Marty, M | 1 |
| Boiron, M | 1 |
| Baĭsogolov, GD | 3 |
| Shakhtarina, SV | 5 |
| Poliakov, VE | 3 |
| Ankudinov, VA | 1 |
| Tsygankin, VI | 3 |
| Makhonova, LA | 1 |
| Heinz, R | 1 |
| Hanak, H | 1 |
| Tsyplenkov, VG | 2 |
| Sviridova, AV | 1 |
| Shishkin, IP | 1 |
| Fuller, LM | 1 |
| Kuentz, M | 2 |
| Reyes, F | 1 |
| Brun, B | 1 |
| Lebourgeois, JP | 1 |
| Bierling, P | 1 |
| Farcet, JP | 1 |
| Vernant, JP | 1 |
| Imbert, M | 1 |
| Le Bezu, M | 1 |
| Rochant, H | 1 |
| Dreyfus, B | 1 |
| Weiss, RB | 2 |
| Issell, BF | 1 |
| Hörnsten, P | 1 |
| Sundman-Engberg, B | 1 |
| Gahrton, G | 1 |
| Johansson, B | 1 |
| Haddad, E | 1 |
| Le Bourgeois, JP | 1 |
| Lobo, P | 1 |
| Pavlovsky, S | 5 |
| Morgenfeld, M | 3 |
| Somoza, N | 2 |
| Magnasco, J | 2 |
| Sackmann Muriel, F | 1 |
| Cavagnaro, F | 1 |
| Suárez, A | 2 |
| Barros, CA | 1 |
| Saslavsky, J | 1 |
| Garay, G | 1 |
| Palau, M | 1 |
| Besuschio, SC | 1 |
| Vialushkin, BIa | 1 |
| Koshel', IV | 1 |
| Andrieu, JM | 3 |
| Casassus, P | 2 |
| Coscas, Y | 1 |
| Darmont, J | 1 |
| Goubeau, C | 1 |
| Katz, M | 1 |
| Jacquillat, C | 2 |
| Tricot, G | 1 |
| Weil, M | 1 |
| Aiba, K | 1 |
| Ogawa, M | 1 |
| Inagaki, J | 1 |
| Horikoshi, N | 1 |
| Ezaki, K | 1 |
| Inoue, K | 1 |
| Dohmyo, M | 1 |
| Nagata, T | 1 |
| Miyamoto, H | 1 |
| Kobayashi, T | 1 |
| Kuraishi, Y | 1 |
| Hansen, HH | 1 |
| Selawry, OS | 1 |
| Spurr, CL | 2 |
| Falkson, G | 2 |
| Brunner, K | 3 |
| Cuttner, J | 2 |
| Sackmann-Muriel, F | 2 |
| Bonesana, AC | 1 |
| Papendieck, C | 1 |
| Penchansky, L | 1 |
| Schwartz, L | 3 |
| Kvicala, R | 1 |
| Sica, M | 1 |
| Ojeda, F | 1 |
| Stäubli, M | 1 |
| Graf, W | 1 |
| Straub, PW | 1 |
| Grunwald, H | 1 |
| Bank, A | 1 |
| Leone, L | 1 |
| Seligman, BR | 1 |
| Silver, RT | 2 |
| Haurani, F | 1 |
| Blom, J | 1 |
| Kotlarek-Haus, S | 4 |
| Gabryś, K | 4 |
| Potoczek, S | 1 |
| Smith, MR | 1 |
| Khanuja, PS | 1 |
| al-Katib, A | 1 |
| Bishop, CR | 1 |
| Andersen, J | 1 |
| Hussein, ME | 1 |
| Karanes, C | 1 |
| Lobo-Sanahuja, F | 1 |
| García, I | 3 |
| Barrantes, JC | 1 |
| Barrantes, M | 1 |
| González, M | 1 |
| Jiménez, R | 1 |
| Preti, A | 1 |
| McLaughlin, P | 1 |
| Swan, F | 1 |
| Rodriguez, A | 1 |
| Besa, P | 1 |
| Allen, PK | 1 |
| Brusamolino, E | 2 |
| Orlandi, E | 2 |
| Canevari, A | 1 |
| Morra, E | 1 |
| Castelli, G | 1 |
| Alessandrino, EP | 1 |
| Pagnucco, G | 2 |
| Bernasconi, P | 1 |
| Astori, C | 1 |
| Lazzarino, M | 2 |
| Fuchs, R | 3 |
| Löffler, M | 3 |
| Pfreundschuh, M | 4 |
| Dölken, G | 2 |
| Gerhartz, H | 3 |
| Hagen-Aukamp, U | 2 |
| Hiller, E | 3 |
| Petsch, S | 2 |
| Pflüger, KH | 3 |
| Rühl, U | 3 |
| Sardaş, S | 1 |
| Erdoğan, F | 1 |
| Sardaş, OS | 1 |
| Cengel, M | 1 |
| Karakaya, AE | 1 |
| Pieresca, C | 1 |
| Narni, F | 1 |
| Grignani, G | 1 |
| Avanzini, P | 1 |
| Partesotti, G | 1 |
| Zinzani, PL | 1 |
| Barbieri, E | 1 |
| Bendandi, M | 1 |
| Perini, F | 1 |
| Gherlinzoni, F | 1 |
| Neri, S | 1 |
| Ammendolia, I | 1 |
| Salvucci, M | 1 |
| Babini, L | 1 |
| Fiacchini, M | 1 |
| Vreugdenhil, G | 1 |
| Jongen-Lavrencic, M | 1 |
| Raemaekers, JM | 1 |
| de Pauw, BE | 1 |
| Illés, A | 1 |
| Bányai, A | 1 |
| Szegedi, G | 1 |
| Fairey, AF | 1 |
| Jones, HW | 1 |
| Sweetenham, JW | 1 |
| Whitehouse, JM | 1 |
| van Leeuwen, FE | 1 |
| Chorus, AM | 1 |
| van den Belt-Dusebout, AW | 1 |
| Hagenbeek, A | 1 |
| Noyon, R | 1 |
| van Kerkhoff, EH | 1 |
| Pinedo, HM | 1 |
| Somers, R | 1 |
| Da, WM | 1 |
| Zhong, JT | 1 |
| Liu, Y | 1 |
| Huang, YS | 1 |
| Bai, H | 1 |
| Wu, XX | 1 |
| Ou, YX | 1 |
| Wang, CB | 1 |
| Xu, SF | 1 |
| Loeffler, M | 2 |
| Ruehl, U | 1 |
| Hasenclever, D | 1 |
| Nisters-Backes, H | 1 |
| Sieber, M | 1 |
| Smith, K | 2 |
| Tesch, H | 1 |
| Geilen, W | 1 |
| Kastrissios, H | 1 |
| Chao, NJ | 1 |
| Blaschke, TF | 1 |
| Ifrah, N | 1 |
| Hunault, M | 1 |
| Jais, JP | 1 |
| Moreau, P | 1 |
| Desablens, B | 1 |
| Briere, J | 1 |
| Le Maignan, C | 1 |
| Shear, NH | 1 |
| Knowles, SR | 1 |
| Shapiro, L | 1 |
| Poldre, P | 1 |
| Ashigbi, MY | 1 |
| Venkatraj, U | 1 |
| Agarwal, V | 1 |
| Bello, J | 1 |
| Zubizarreta, P | 1 |
| Gallo, G | 1 |
| Scopinaro, M | 1 |
| Alderete, D | 1 |
| Alfaro, E | 1 |
| Casak, S | 1 |
| Chantada, G | 1 |
| Felice, MS | 1 |
| Quinteros, R | 1 |
| Propert, KJ | 2 |
| Glicksman, A | 1 |
| Peterson, B | 1 |
| Anderson, JR | 2 |
| Gottlieb, A | 2 |
| Kaufman, T | 1 |
| Anselmo, AP | 1 |
| Klersy, C | 1 |
| Santoro, M | 1 |
| Lunghi, F | 1 |
| Maurizi-Enrici, R | 1 |
| Baroni, CD | 1 |
| Mandelli, F | 1 |
| Bernasconi, C | 2 |
| Tsushita, K | 1 |
| Utsumi, M | 1 |
| Shimoyama, M | 1 |
| Harrison, CN | 1 |
| Gregory, W | 1 |
| Hudson, GV | 1 |
| Devereux, S | 2 |
| Goldstone, AH | 1 |
| Hancock, B | 1 |
| Winfield, D | 1 |
| MacMillan, AK | 1 |
| Hoskin, P | 1 |
| Newland, AC | 1 |
| Milligan, D | 1 |
| Linch, DC | 2 |
| Bertè, R | 1 |
| Petrilli, MP | 1 |
| Ghirardelli, ML | 1 |
| Ascari, E | 1 |
| Shamash, J | 1 |
| Walewski, J | 1 |
| Apostolidis, J | 1 |
| Wilson, AM | 1 |
| Foran, JM | 1 |
| Gupta, RK | 1 |
| Rohatiner, AZ | 1 |
| Kelsey, SM | 1 |
| Lister, TA | 1 |
| Leong, T | 1 |
| Oken, MM | 1 |
| Neiman, RS | 1 |
| Habermann, TM | 1 |
| Bennett, JM | 1 |
| Schuster, S | 1 |
| Glick, JH | 1 |
| Stuart, MJ | 1 |
| Chao, NS | 1 |
| Horning, SJ | 2 |
| Wong, RM | 1 |
| Negrin, RS | 1 |
| Johnston, LJ | 1 |
| Shizuru, JA | 1 |
| Long, GD | 1 |
| Blume, KG | 1 |
| Stockerl-Goldstein, KE | 1 |
| Vickery, IM | 1 |
| Midda, M | 1 |
| Osieka, R | 1 |
| Bruntsch, U | 1 |
| Gallmeier, WM | 1 |
| Seeber, S | 1 |
| Schmidt, CG | 1 |
| Levi, JA | 2 |
| Garrett, MJ | 1 |
| Das, S | 1 |
| Smith, JD | 1 |
| Freedman, LS | 1 |
| Dold, U | 1 |
| Porzig, KJ | 1 |
| Portlock, CS | 1 |
| Robertson, A | 1 |
| Maurice, P | 1 |
| Glidewell, O | 1 |
| Carey, R | 1 |
| Pas, AT | 1 |
| Cornell, CJ | 1 |
| Burningham, RA | 1 |
| de Bonesana, AC | 1 |
| Bezares, R | 1 |
| Pileggi, J | 1 |
| Lein, JM | 1 |
| Macchi, A | 1 |
| Calabria, SI | 1 |
| Garay, GE | 1 |
| de Sica, SC | 1 |
| Besuschio, S | 1 |
| Crafts, DC | 1 |
| Townsend, J | 1 |
| Wilson, CB | 1 |
| Levin, VA | 1 |
| Olweny, CL | 1 |
| Katongole-Mbidde, E | 1 |
| Kiire, C | 1 |
| Lwanga, SK | 1 |
| Magrath, I | 1 |
| Ziegler, JL | 1 |
| Durant, JR | 1 |
| Bartolucci, A | 1 |
| Gams, RA | 1 |
| Dorfman, RF | 1 |
| Velez-Garcia, E | 1 |
| Kvols, LK | 1 |
| Wasserman, TH | 1 |
| Slavik, M | 1 |
| Carter, SK | 1 |
| Wołowiec, D | 1 |
| Kuliszkiewicz-Janus, M | 1 |
| Filip, A | 1 |
| Santarelli, MT | 2 |
| Muriel, FS | 2 |
| Fernández, I | 1 |
| Montero, C | 2 |
| Sanahuja, FL | 2 |
| Magnasco, H | 1 |
| Costa, A | 1 |
| Longo, DL | 2 |
| DeVita, VT | 2 |
| Sen, P | 1 |
| Bailey, NM | 1 |
| Liang, JC | 1 |
| Gaynor, JJ | 1 |
| Merke, DP | 1 |
| Caravelli, J | 2 |
| Chapman, D | 2 |
| Yahalom, J | 1 |
| McClain, KL | 1 |
| Heise, R | 1 |
| Day, DL | 1 |
| Lee, CK | 1 |
| Woods, WG | 1 |
| Aeppli, D | 1 |
| Viviani, S | 3 |
| Santoro, A | 4 |
| Negretti, E | 1 |
| Bonfante, V | 3 |
| Valagussa, P | 4 |
| al-Idrissi, HY | 1 |
| Ibrahim, EM | 1 |
| Duffey, PL | 1 |
| Hubbard, SM | 1 |
| Phares, JC | 1 |
| Bastian, AW | 1 |
| Jaffe, ES | 1 |
| Young, RC | 1 |
| Koza, I | 1 |
| Bohunický, L | 1 |
| Mociková, K | 1 |
| Gyárfás, J | 1 |
| Svancárová, L | 1 |
| Mardiak, J | 1 |
| Spánik, S | 1 |
| Fuchsberger, P | 1 |
| Thalmeinerová, Z | 1 |
| Sufliarsky, J | 1 |
| Szántó, I | 1 |
| Fleischmann, T | 1 |
| Eckhardt, S | 1 |
| Demina, EA | 1 |
| Kondrat'eva, NF | 1 |
| Pirogova, NA | 1 |
| Afanasova, NV | 2 |
| von Hirschhausen, R | 1 |
| Steinke, B | 1 |
| Saal, JG | 1 |
| Marton, E | 1 |
| Istvan, L | 1 |
| Arkhipov, AI | 2 |
| Vilensky, BS | 1 |
| Selassie, TG | 1 |
| Vaughan Hudson, G | 1 |
| Vaughan Hudson, B | 1 |
| Carey, PJ | 1 |
| Kholin, AV | 1 |
| Frizzera, G | 1 |
| Sciborski, R | 2 |
| Williams, SF | 1 |
| Ultmann, JE | 1 |
| Gaynor, E | 1 |
| Watson, S | 1 |
| Georgii, A | 1 |
| Zori Comba, A | 1 |
| Herold, M | 2 |
| Anger, G | 2 |
| Höche, D | 2 |
| Kästner, R | 2 |
| Pfreundschuh, MG | 1 |
| Schoppe, WD | 1 |
| Schiffer, CA | 1 |
| Congiu, AM | 1 |
| Gaozza, E | 1 |
| Mazza, P | 1 |
| Ricci, P | 1 |
| Visani, G | 1 |
| Meloni, G | 1 |
| Cimino, G | 1 |
| Mangoni, L | 1 |
| Coser, P | 1 |
| Cervantes, F | 2 |
| Reverter, JC | 2 |
| Bladé, J | 1 |
| Gaynor, J | 1 |
| Merke, D | 1 |
| Keinert, K | 1 |
| Wutke, K | 1 |
| Makhomova, LA | 1 |
| Goldobenko, GV | 1 |
| Susuleva, NA | 1 |
| Lagarde, P | 2 |
| Bonichon, F | 2 |
| Eghbali, H | 2 |
| de Mascarel, I | 2 |
| Chauvergne, J | 2 |
| Hoerni, B | 2 |
| Kindzel'skiĭ, LP | 1 |
| Gubareva, AA | 1 |
| Catanese, J | 1 |
| Dutcher, JP | 1 |
| Dorfman, HD | 1 |
| Andres, DF | 1 |
| Schaefer, HJ | 1 |
| Ollenschläger, G | 1 |
| Mödder, B | 1 |
| Maschio, M | 1 |
| Corrado, C | 1 |
| Magnasco, O | 1 |
| Schellong, G | 1 |
| Brämswig, JH | 1 |
| Schwarze, EW | 1 |
| Wannenmacher, M | 1 |
| Vilenskiĭ, BS | 1 |
| Astapov, BM | 1 |
| Phillips, GL | 1 |
| Reece, DE | 1 |
| Sans-Sabrafen, J | 1 |
| Pedro Olivé, C | 1 |
| Buxó Costa, J | 1 |
| Pardo Peret, P | 1 |
| Rodríguez Ferrera, JC | 1 |
| Woessner, S | 1 |
| Galofré, M | 1 |
| Rodríguez Méndez, F | 1 |
| Baysogolov, GD | 1 |
| Tseng, A | 1 |
| Jacobs, C | 1 |
| Coleman, CN | 1 |
| Lewis, BJ | 1 |
| Robak, T | 1 |
| Krykowski, E | 1 |
| Olszańska-Skorek, T | 1 |
| Urbańska-Ryś, H | 1 |
| Dmochowska, M | 1 |
| Chojnowski, K | 1 |
| Blokhina, NG | 1 |
| Aliev, BM | 1 |
| Kruglova, GV | 1 |
| Kaverzneva, MM | 1 |
| Vasygova, NF | 1 |
| Cramer, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Non Randomized, Multicenter, Prospective Pediatric Hodgkin Lymphoma Treatment Trial Stratified According to Initial Risk Factors and Response to Chemotherapy, Reduced Cumulative Doses of Antineoplastic Agents and Radiotherapy.[NCT03500133] | Phase 4 | 500 participants (Anticipated) | Interventional | 2017-10-06 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for lomustine and Granuloma, Hodgkin
| Article | Year |
|---|---|
Treatment of Hodgkin lymphoma: the past, present, and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cycl | 2008 |
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease Progress | 2010 |
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bowen's Disease; Co | 2003 |
Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1982 |
The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
Topics: Bone Marrow; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Gastrointestinal Neoplasms; Hod | 1982 |
[Treatment of advanced stage Hodgkin disease with CCNU, etoposide and prednimustine (CEP)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Etoposide; Fe | 1994 |
Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis.
Topics: Antineoplastic Agents; Dapsone; Hidradenitis; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; | 1996 |
[The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1998 |
Clinical comparison of the nitrosoureas.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carmustine; Chemical Phenomena; C | 1975 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality | 1992 |
Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1990 |
Nitrosourea derivatives for the treatment of Hodgkin's disease involving the central nervous system: a study of 23 cases.
Topics: Adolescent; Adult; Brain Diseases; Female; Hodgkin Disease; Humans; Lomustine; Male; Methylnitrosour | 1990 |
[Results of the treatment of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1986 |
[Rescue treatment in Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1987 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
Etoposide: fifteen years experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Hodgkin Dise | 1989 |
Mediastinal osteosarcoma with extension to lungs in a patient treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1988 |
Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.
Topics: Alkylating Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marro | 1986 |
57 trials available for lomustine and Granuloma, Hodgkin
| Article | Year |
|---|---|
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2016 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carbopl | 2012 |
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 2011 |
Autologous noncryopreserved hematopoietic stem cell transplant with CEAM as a modified conditioning regimen in patients with Hodgkin lymphoma: a single-center experience with a new protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cryopreservation; Cytarabine; Eto | 2012 |
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-M | 2002 |
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distributio | 2003 |
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2005 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
Oral combination chemotherapy in the treatment of AIDS-associated Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy | 2005 |
Treatment of advanced untreated Hodgkin's disease with SCAB--an alternative to MOPP.
Topics: Adult; Bleomycin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodg | 1981 |
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.
Topics: Adult; Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Female; | 1982 |
Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Prot | 1983 |
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1984 |
Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Top | 1983 |
The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combin | 1984 |
Combined modality in Hodgkin's disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as T | 1984 |
Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Admini | 1981 |
[Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Dru | 1982 |
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
Topics: Adult; Carmustine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration S | 1981 |
Hodgkin's disease in childhood: therapy results in Argentina.
Topics: Adolescent; Antineoplastic Agents; Argentina; Child; Child, Preschool; Clinical Trials as Topic; Cyc | 1981 |
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemat | 1980 |
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
CEP regimen (CCNU, etoposide, prednimustine) for relapsed/refractory Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance | 1994 |
Phase-II trial with M-CAVe-CEC as a salvage chemotherapeutic regimen for early relapsed or primary refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; D | 1994 |
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1995 |
Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1997 |
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survi | 1998 |
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2000 |
Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; De | 2000 |
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 2001 |
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pro | 2001 |
Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
Topics: Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Leukopenia; Lomustine; Lymphoma, Non-Hodg | 1978 |
Combined chemotherapy cyclophosphamide, vinblastine, procarbazine and prednisone (CVPP) vs. CVPP plus CCNU (CCVPP) in Hodgin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Administr | 1979 |
Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
Topics: Administration, Oral; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug | 1976 |
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1992 |
[Early results of the treatment of Hodgkin's disease in adults using the seven-drug cytostatic protocol].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protoco | 1992 |
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A & B Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1992 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality | 1992 |
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1990 |
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dose-Re | 1991 |
Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 1991 |
Treatment of resistant Hodgkin's disease with CCNU, etoposide and prednimustine (CEP).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etopos | 1991 |
[Experiences with a new second-line protocol in the treatment of pretreated and advanced Hodgkin disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; D | 1990 |
Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studi | 1990 |
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1986 |
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials as T | 1986 |
[Intermediate results of the German Hodgkin's disease therapy study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1986 |
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali | 1987 |
[Preliminary results of cyclically alternating chemotherapy (CVPP/DBVCy) in advanced Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Clinic | 1987 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1989 |
[Evaluation of 5-year results of the scheduled treatment of lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1989 |
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1988 |
An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1988 |
The efficiency of different combined treatment programs (combination chemotherapy-radiotherapy) used for stage I-II Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1987 |
[Treatment of patients with lymphogranulomatosis, stages I and II (preliminary results of a randomized study--radiation and complex therapy)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1985 |
Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Tria | 1985 |
82 other studies available for lomustine and Granuloma, Hodgkin
| Article | Year |
|---|---|
A forgotten friend: CCNU as palliative monotherapy in relapsed Hodgkin lymphoma.
Topics: Friends; Hodgkin Disease; Humans; Lomustine; Lymphoma, Non-Hodgkin; Palliative Care | 2021 |
LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy.
Topics: Adolescent; Adult; Autografts; Carmustine; Child; Child, Preschool; Cohort Studies; Cyclophosphamide | 2016 |
[Clinical features and combined treatment of the central nervous system in Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols | 2008 |
Modified BEAM conditioning regimen in patients with Hodgkin and non-Hodgkin lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Trans | 2012 |
LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin | 2007 |
A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclop | 2008 |
Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administra | 1980 |
Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Drug Therapy, Co | 1980 |
[CCNU, bleomycin, and vincristine (vinblastine) combination therapy in the treatment of resistant lymphoma (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgki | 1980 |
Single agent palliative chemotherapy for end-stage Hodgkin's disease.
Topics: Adolescent; Adult; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Nitrosourea Compou | 1982 |
[Chemotherapy in pretreated Hodgkin's disease with lomustine, bleomycin, vinblastine and dexamethasone].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosph | 1983 |
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; H | 1983 |
Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Res | 1983 |
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1984 |
[3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1984 |
[A combined therapy program for children with lymphogranulomatosis].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Combine | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Dis | 1984 |
[Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
[Secondary malignant tumors following treatment of Hodgkin's disease].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 1984 |
Diagnosis and management of Hodgkin's disease in the adult.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
Early response to chemotherapy as a prognostic factor in Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
CCNU toxicity after an overdose in a patient with Hodgkin's disease. Effects on colony-forming cells (CFU-C) and colony-stimulating activity (CSA).
Topics: Animals; Colony-Forming Units Assay; Dogs; Granulocytes; Hematopoietic Stem Cells; Hodgkin Disease; | 1983 |
Liver complications in lymphomas treated with a combination of chemotherapy and radiotherapy: preliminary results.
Topics: Adult; Aged; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Liver; Lomusti | 1983 |
[Treatment procedure in generalized lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1982 |
[Combination chemotherapy of Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Ther | 1982 |
[Pruritus in Hodgkin's disease responding to cimetidine].
Topics: Adult; Cimetidine; Female; Guanidines; Hodgkin Disease; Humans; Lomustine; Prednisone; Procarbazine; | 1981 |
[Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Ep | 1995 |
Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fe | 1994 |
Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyta | 1994 |
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1994 |
Sister chromatid exchange studies for monitoring DNA damage in lymphocytes of malignant lymphoma patients under cytostatic therapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosph | 1994 |
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorub | 1993 |
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Case-Co | 1994 |
Prolonged disease-free survival after ablative chemoradiotherapy and autologous bone marrow transplantation in adult malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow | 1993 |
Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patients.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Biotransformation; Bone Marrow Transplantation; | 1996 |
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1996 |
Intracranial Hodgkin's disease in two patients with familial Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modalit | 1997 |
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con
Topics: Abdomen; Actuarial Analysis; Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; | 1998 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; | 1999 |
Dental complications of cytotoxic therapy in Hodgkin's disease--a case report.
Topics: Adult; Bleomycin; Female; Herpes Zoster; Hodgkin Disease; Humans; Lomustine; Mandibular Diseases; Os | 1976 |
[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hod | 1976 |
Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin.
Topics: Adolescent; Adult; Aged; Bleomycin; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; | 1977 |
Long term experience with combination chemotherapy in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; | 1977 |
[Cytostatic chemotherapy of lymphogranulomatosis].
Topics: Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combinat | 1978 |
Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
Topics: Adolescent; Adult; Bleomycin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgk | 1978 |
Combination chemotherapy with doxorubicin and lomustine. Treatment of refractory Hodgkin's disease.
Topics: Administration, Oral; Adult; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Fe | 1977 |
Development of Hodgkin's disease in a patient receiving procarbazine, CCNU, and vincristine therapy for a gemistocytic astrocytoma.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Drug Therapy, Combination; Female; Hodgkin Dise | 1978 |
Childhood Hodgkin's disease in Uganda: a ten year experience.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gynec | 1978 |
Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
Topics: Adult; Bone Marrow; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Femal | 1977 |
Lomustine (CeeNU).
Topics: Brain Neoplasms; Glioma; Hodgkin Disease; Humans; Lomustine; Nitrosourea Compounds | 1976 |
Role of radiation therapy in advanced Hodgkin's disease--as yet, an answer? Still a question?
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1992 |
Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chromosomes; Dacarbazi | 1990 |
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Et | 1990 |
Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Dacarbazine; Doxorubi | 1991 |
[The combined therapy of stage-II lymphogranulomatosis: the effect of splenectomy and the time period for achieving full remission on treatment efficacy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1991 |
[The combined (polychemical and radiation) and drug treatment of lymphogranulomatosis patients with generalized lung involvement (stage IV)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin | 1991 |
Treatment of advanced Hodgkin's disease with lomustine, etoposide, and prednimustine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hodgkin Disease; Humans; Lomustine; Predn | 1990 |
[Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin | 1990 |
An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNU.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambuci | 1990 |
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg | 1986 |
[Early results of the treatment of Hodgkin's disease with alternating use in the CVPP and ABVD protocol].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1986 |
Management of advanced, resistant Hodgkin's disease and non-Hodgkin's lymphoma: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; | 1986 |
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 1987 |
Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Follow-Up Stu | 1988 |
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1988 |
[Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do | 1988 |
[Treatment of Hodgkin's disease with alternately used drug combinations CVPP/ABVD].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1988 |
Reduced combined radiotherapy and chemotherapy for Hodgkin's disease--risk-adapted treatment approach.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1989 |
Third-line salvage chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1985 |
Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Hodg | 1989 |
[Indirect endolymphatic chemotherapy of patients with lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin Disease; Humans; Injection | 1989 |
[Oral polychemotherapy in far advanced recurrences of Hodgkin's disease].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Etoposide | 1988 |
[Use of nitrosourea derivatives in the treatment of patients with Hodgkin's disease with lesions of the central nervous system].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Drug Evaluation; | 1988 |
[Status of the heart during a combined method of treating patients with stage I to II lymphogranulomatosis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1988 |
Brief chemotherapy associated with extended field radiotherapy in Hodgkin's disease. Long-term results in a series of 102 patients with clinical stages I-IIIA.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Follow-Up | 1988 |
[Hodgkin's disease. Study of 100 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1987 |
Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocol | 1987 |
Treatment of advanced resistant Hodgkin's disease with lomustine, etoposide, and prednimustine.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Etoposide; Hodgkin Disease | 1986 |
[Use of lomustine, teniposide, procarbazine and prednisone (LTPP) in the treatment of terminal-state Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1986 |
[The main stages in the complex treatment of children with lymphogranulomatosis (Hodgkin's disease)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1985 |